ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
A scientist at Star Clinic, a regenerative medical center in Tokyo, transfers cells extracted from a patient to a container for use in stem cell therapy. (Photo by Yuki Kohara)
The Big Story

Defying death: Japan and Singapore lead Asia's stem cell research race

In the world's fastest-aging societies, regenerative therapies attract the rich and curious

LOUIS RAYMOND, Contributing writer | Singapore

SINGAPORE -- Businessman Dato Shaun Lim was a successful real estate mogul until he suddenly decided to switch careers in 2019. Flicking through the movie list on an international flight, he chanced to watch a documentary about "geroscience" -- the study of aging and how it can be stopped. That struck Lim as a rather good business proposition. Later that year, Lim would co-found Regenosis, a clinic and geroscience research company, devoted to stem cell therapies designed to halt or reverse the aging process.

Today, the fruits of Lim's investment can be found at the Southern end of the Malay Peninsula, in the city of Iskandar Puteri, which is mostly home to people working in downtown Singapore, an hour away by train.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more